News & Analysis as of August 21, 2025

Pharmaceutical Industry

+ Follow

A repository for the most well-read content on JD Supra at any given time, along with occasional roundups of popular content by specific topic. Also stop by for monthly recaps of hot articles for the previous... more +

Trending in Telehealth: June 2025

McDermott Will & Schulte on 7/24/2025

Trending in Telehealth highlights monthly state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and...more

Most-Favored-Nation Drug Pricing in the U.S.

Brownstein Hyatt Farber Schreck on 6/10/2025

On May 12, President Trump issued an Executive Order (EO) on drug pricing: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The EO requires a 30-day government negotiation with drug companies...more

Challenges to LDT Final Rule Continue as Rule Goes into Effect

Polsinelli on 7/29/2024

As discussed in our May 6, 2024, Client Alert, earlier this year FDA issued its Final Rule for the regulation of laboratory-developed tests (LDTs) that the FDA has historically treated with enforcement discretion. A week...more

DC District Court Strikes Down 340B Orphan Drug Rule

Foley Hoag LLP on 6/7/2014

On May 23, Judge Contreras of the U.S. District Court for the District of Columbia (DC District Court) ruled that the Health Resources and Services Administration (HRSA) did not have the statutory authority to promulgate its...more

4 Results

View per page

Page: of 1

Today's Popular Updates › Rulemaking Process › Pharmaceutical Industry

Trending in Telehealth: June 2025

Most-Favored-Nation Drug Pricing in the U.S.

Challenges to LDT Final Rule Continue as Rule Goes into Effect

DC District Court Strikes Down 340B Orphan Drug Rule

"My best business intelligence, in one easy email…"